ARROWHEAD PHARMACEUTICALS, INC.·4

Jan 11, 8:35 PM ET

Vakiener Victoria 4

4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 11, 2023

Insider Transaction Report

Form 4
Period: 2023-01-10
Transactions
  • Award

    Common Stock

    2023-01-10+7,86723,284 total
  • Award

    Common Stock

    2023-01-10+4,5934,593 total
    Exercise: $33.03From: 2024-01-10Exp: 2033-01-10Common Stock (4,593 underlying)
  • Disposition to Issuer

    Common Stock

    2023-01-101,76415,417 total
Footnotes (4)
  • [F1]Correction to previously granted award from 17,181 to 15,417.
  • [F2]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
  • [F3]Includes a total of 15,417 shares underlying restricted stock units, which vest over three years.
  • [F4]Represents options, which will vest in one installment on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION